Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

The utility of the IGF-I generation test in children with chronic kidney disease.

Al-Uzri A, Swinford RD, Nguyen T, Jenkins R, Gunsul A, Kachan-Liu SS, Rosenfeld R.

Pediatr Nephrol. 2013 Dec;28(12):2323-33. doi: 10.1007/s00467-013-2570-0. Epub 2013 Sep 7.

PMID:
24013497
2.
3.
4.

Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?

Cianfarani S, Tondinelli T, Spadoni GL, Scirè G, Boemi S, Boscherini B.

Clin Endocrinol (Oxf). 2002 Aug;57(2):161-7.

PMID:
12153594
5.

IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.

Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.

Horm Res. 2005;64(2):68-76. Epub 2005 Aug 19.

PMID:
16113581
7.

Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.

Cotterill AM, Camacho-Hübner C, Duquesnoy P, Savage MO.

Clin Endocrinol (Oxf). 1998 Jun;48(6):719-24.

PMID:
9713560
8.

Evaluation of insulin-like growth factor (IGF)-I and IGF binding protein-3 generation test in short stature.

Darendeliler F, Ocal C, Baş F.

J Pediatr Endocrinol Metab. 2005 May;18(5):443-52.

PMID:
15921173
9.

Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.

Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG; American Norditropin Study Group.

J Clin Endocrinol Metab. 2007 Jul;92(7):2480-6. Epub 2007 Mar 13.

PMID:
17356043
10.

Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature.

Blair JC, Camacho-Hübner C, Miraki Moud F, Rosberg S, Burren C, Lim S, Clayton PE, Bjarnason R, Albertsson-Wikland K, Savage MO.

Clin Endocrinol (Oxf). 2004 Feb;60(2):163-8; discussion 161-2.

PMID:
14725676
12.
13.

European multicentre study in children born small for gestational age with persistent short stature: comparison of continuous and discontinuous growth hormone treatment regimens.

Phillip M, Lebenthal Y, Lebl J, Zuckerman-Levin N, Korpal-Szczyrska M, Marques JS, Steensberg A, Jons K, Kappelgaard AM, Ibanez L; European Norditropin SGA Study Group.

Horm Res. 2009 Jan;71(1):52-9. doi: 10.1159/000173742. Epub 2008 Nov 27.

PMID:
19039237
14.

Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.

Hokken-Koelega AC, van Pareren Y, Sas T, Arends N.

Horm Res. 2003;60 Suppl 3:113-4.

PMID:
14671407
15.

Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.

Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17.

PMID:
11422104
16.

Final height and insulin-like growth factor-1 in children with medulloblastoma treated with growth hormone.

Chae HW, Park YS, Kim DS, Kwon AR, Kim HS, Kim DH.

Childs Nerv Syst. 2013 Oct;29(10):1859-63. doi: 10.1007/s00381-013-2124-6. Epub 2013 Jun 18.

PMID:
23775040
19.

The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.

Melis D, Pivonello R, Parenti G, Della Casa R, Salerno M, Balivo F, Piccolo P, Di Somma C, Colao A, Andria G.

J Pediatr. 2010 Apr;156(4):663-70.e1. doi: 10.1016/j.jpeds.2009.10.032. Epub 2009 Dec 21.

PMID:
20022338

Supplemental Content

Support Center